218 related articles for article (PubMed ID: 1097498)
1. Prolongation of allograft survival in mice by administration of anti-Thy 1 serum. I. Mediation by in vivo activation of regulatory T cells.
Gelfand MC; Paul WE
J Immunol; 1975 Jul; 115(1):1-4. PubMed ID: 1097498
[TBL] [Abstract][Full Text] [Related]
2. Specific unresponsiveness to skin allografts in anti-lymphocyte serum-treated, marrow-injected mice: participation of donor marrow-derived suppressor T cells.
Maki T; Gottschalk R; Wood ML; Monaco AP
J Immunol; 1981 Oct; 127(4):1433-8. PubMed ID: 6168692
[TBL] [Abstract][Full Text] [Related]
3. Cellular cooperation during in vivo anti-hapten antibody responses. III. The helper cell activity of activated thymocytes, of spleen cells treated with anti-theta serum, and of spleen cells from anti-thymocyte serum-treated or adult thymectomized donors.
Janeway CA
J Immunol; 1975 Apr; 114(4):1408-14. PubMed ID: 1078836
[TBL] [Abstract][Full Text] [Related]
4. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
Dono K; Maki T; Wood ML; Monaco AP
Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
[TBL] [Abstract][Full Text] [Related]
5. Suppressor cell activation by anti-thy 1.2 in NZB/WF1 mice.
Klassen LW; Zarate A; Gelfand MC; Steinberg AD
J Immunol; 1977 Dec; 119(6):2067-72. PubMed ID: 334981
[No Abstract] [Full Text] [Related]
6. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
[TBL] [Abstract][Full Text] [Related]
7. Induction of suppressor cell mechanism in antilymphocyte serum-induced skin allograft tolerance in mice.
Rieger M; Hilgert I; Kristofová H; Vlachov K
Folia Biol (Praha); 1979; 25(4):220-30. PubMed ID: 159195
[TBL] [Abstract][Full Text] [Related]
8. Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice.
Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Maeda T; Ando T; Nomoto K
J Immunol; 1991 Mar; 146(5):1402-9. PubMed ID: 1671578
[TBL] [Abstract][Full Text] [Related]
9. Mouse skin graft prolongation with donor strain bone marrow and anti-lymphocyte serum: surface markers of the active bone marrow cells.
De Fazio S; Hartner WC; Monaco AP; Gozzo JJ
J Immunol; 1985 Nov; 135(5):3034-8. PubMed ID: 2864375
[TBL] [Abstract][Full Text] [Related]
10. Effects of restoring lethally irradiated mice with anti-Thy 1.2-treated bone marrow: graft-vs-host, host-vs-graft, and mitogen reactivity.
Norin AJ; Emeson EE
J Immunol; 1978 Mar; 120(3):754-8. PubMed ID: 24664
[TBL] [Abstract][Full Text] [Related]
11. Distinct properties of Thy-1 antibodies elicited in rats by immunization with mouse brain.
Rabinowitz R; Sharav Y; Schlesinger M
Eur J Immunol; 1977 Jul; 7(7):492-6. PubMed ID: 330171
[TBL] [Abstract][Full Text] [Related]
12. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
Margenthaler JA; Flye MW
J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
[TBL] [Abstract][Full Text] [Related]
13. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
14. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
15. Suppressor cells and intrathymic inoculation of donor alloantigens in cardiac transplantation.
Shen Z; Mohiuddin M; DiSesa VJ
Ann Thorac Surg; 1995 Dec; 60(6):1683-5. PubMed ID: 8787463
[TBL] [Abstract][Full Text] [Related]
16. Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier.
Blazar BR; Taylor PA; Snover DC; Bluestone JA; Vallera DA
J Immunol; 1993 Jan; 150(1):265-77. PubMed ID: 8417127
[TBL] [Abstract][Full Text] [Related]
17. T cell-derived factor alone or in combination with immunosuppressive drugs augments prolongation of allogeneic skin graft survival in mice receiving donor-specific transfusion.
Gorczynski RM; Boulanger M; Lau C
J Immunol; 1987 May; 138(10):3197-202. PubMed ID: 2952712
[TBL] [Abstract][Full Text] [Related]
18. Cellular origins and target cells of immunoregulatory factors in mice with disseminated histoplasmosis.
Deepe GS; Watson SR; Bullock WE
J Immunol; 1984 Apr; 132(4):2064-71. PubMed ID: 6230399
[TBL] [Abstract][Full Text] [Related]
19. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
Gao L; Woo J; Buelow R
J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cytotoxic lymphocyte responses in vitro by alloantigen-activated spleen cells.
Truitt GA; Rich RR; Rich SS
J Immunol; 1977 Jul; 119(1):31-7. PubMed ID: 874322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
